FDA Panel Urges Approval for Pfizer Arthritis Drug Tofacitinib - Industry Week

"And at the 10 milligram dose it showed that it decreases the destructive nature of the arthritis. It slows down the progression of anatomic changes caused by rheumatoid arthritis." Unlike biologics such as Humira that are injected, tofacitinib ...

FDA panel urges approval for Pfizer arthritis drug - medicalxpress.com

An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer. Tofacitinib, taken orally, could serve as an alternative ...

FDA committee urges approval of new Pfizer arthritis treatment - Raw Story

in patients who have had inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs), such as methotrexate or leflunomide. Those panelists said more data was needed to show whether there are safety issues over the long term.

Manchester speaks out for Lupus awareness - Mount Airy News

She said most lupus patients take Tramadol, Zofran, Celebrex, Cyclobenzaprine, Lyrica, Phenergan, Plaquenil, Prednisone, Prilosec, Vitamin D, Flexeril, Naprosyn, Methotrexate, Azathioprine, Leflunomide and Benylysta. She has osteopenia/osteoporosis ...

Sarcoidosis therapeutics market is forecast to witness static growth until 2019 - Transworld News

Mycophenolate mofetil and leflunomide), Tumor Necrosis Factor (TNF) alpha blockers (infliximab, etanercept and adalimumab), anti-malarial drugs (chloroquine and hydroxychloroquine), and other anti-inflammatory drugs. The static growth of the sarcoidosis ...

Serious skin reactions linked to TNF-alpha antagonists - Xagena Medical News

and Leflunomide ) reported as co-suspect medications. Twelve patients required hospitalization due to their cutaneous reactions. From the date of approval in November 1998 to November 2006, FDA received 22 reports of cases of severe cutaneous adverse ...